Patents by Inventor DMI BIOSCIENCES, INC

DMI BIOSCIENCES, INC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF T-CELL MEDIATED DISEASES
    Publication number: 20130079284
    Abstract: The invention provides a method of treating T-cell mediated diseases and a method of inhibiting the activation of T-cells using certain diketopiperazines. The invention also provides methods of synthesizing diketopiperazines and pharmaceutical compositions comprising certain diketopiperazines. The invention further provides methods of making improved pharmaceutical compositions of proteins and peptides by either increasing or decreasing the content of diketopiperazines in the compositions and the resultant improved pharmaceutical compositions.
    Type: Application
    Filed: November 16, 2012
    Publication date: March 28, 2013
    Applicant: DMI BIOSCIENCES, INC.
    Inventor: DMI BIOSCIENCES, INC.
  • TREATMENT OF T-CELL MEDIATED DISEASES
    Publication number: 20130071448
    Abstract: The invention provides a method of treating T-cell mediated diseases and a method of inhibiting the activation of T-cells using certain diketopiperazines. The invention also provides methods of synthesizing diketopiperazines and pharmaceutical compositions comprising certain diketopiperazines. The invention further provides methods of making improved pharmaceutical compositions of proteins and peptides by either increasing or decreasing the content of diketopiperazines in the compositions and the resultant improved pharmaceutical compositions.
    Type: Application
    Filed: November 14, 2012
    Publication date: March 21, 2013
    Applicant: DMI BIOSCIENCES, INC.
    Inventor: DMI Biosciences, Inc.
  • TREATMENT OF T-CELL MEDIATED DISEASES
    Publication number: 20130072684
    Abstract: The invention provides a method of treating T-cell mediated diseases and a method of inhibiting the activation of T-cells using certain diketopiperazines. The invention also provides methods of synthesizing diketopiperazines and pharmaceutical compositions comprising certain diketopiperazines. The invention further provides methods of making improved pharmaceutical compositions of proteins and peptides by either increasing or decreasing the content of diketopiperazines in the compositions and the resultant improved pharmaceutical compositions.
    Type: Application
    Filed: November 14, 2012
    Publication date: March 21, 2013
    Applicant: DMI BIOSCIENCES, INC.
    Inventor: DMI Biosciences, Inc.
  • TREATMENT OF T-CELL MEDIATED DISEASES
    Publication number: 20130071436
    Abstract: The invention provides a method of treating T-cell mediated diseases and a method of inhibiting the activation of T-cells using certain diketopiperazines. The invention also provides methods of synthesizing diketopiperazines and pharmaceutical compositions comprising certain diketopiperazines. The invention further provides methods of making improved pharmaceutical compositions of proteins and peptides by either increasing or decreasing the content of diketopiperazines in the compositions and the resultant improved pharmaceutical compositions.
    Type: Application
    Filed: November 14, 2012
    Publication date: March 21, 2013
    Applicant: DMI BIOSCIENCES, INC.
    Inventor: DMI BIOSCIENCES, INC.
  • TREATMENT OF T-CELL MEDIATED DISEASES
    Publication number: 20130065839
    Abstract: The invention provides a method of treating T-cell mediated diseases and a method of inhibiting the activation of T-cells using certain diketopiperazines. The invention also provides methods of synthesizing diketopiperazines and pharmaceutical compositions comprising certain diketopiperazines. The invention further provides methods of making improved pharmaceutical compositions of proteins and peptides by either increasing or decreasing the content of diketopiperazines in the compositions and the resultant improved pharmaceutical compositions.
    Type: Application
    Filed: November 14, 2012
    Publication date: March 14, 2013
    Applicant: DMI BIOSCIENCES, INC.
    Inventor: DMI BIOSCIENCES, INC